Group 1 - The core point of the article is that Jindawei has received a patent for a coenzyme Q10 oil preparation method, which may enhance its product offerings and market position [1] - Jindawei's revenue composition for the first half of 2025 shows that industrial revenue accounts for 98.5%, pharmaceutical raw materials for 1.43%, and other businesses for 0.07% [1] - As of the report, Jindawei's market capitalization stands at 11.4 billion yuan [1]

Core Viewpoint - The company, Jin Da Wei, and its subsidiary, Xiamen Jin Da Wei Biotechnology Co., Ltd., have received an invention patent certificate from the National Intellectual Property Administration for a coenzyme Q10 oil preparation and its manufacturing method, which enhances the company's technological innovation and strengthens its core competitiveness [1] Group 1 - The patent is beneficial for the company's technological innovation [1] - The patent contributes to the improvement of the intellectual property protection system [1] - The patent enhances the company's core competitiveness [1]

近日，厦门金达威集团股份有限公司及子公司厦门金达威生物科技有限公司收到国家知识产权局颁发的 发明专利证书。发明名称为"一种辅酶Q10油剂及其制备方法和应用"，专利号ZL202310111297.8，申请 日为2023年，专利权期限二十年，授权公告日为2025年。该发明涉及辅酶Q10技术领域，其辅酶Q10油 剂中辅酶Q10高含量下能稳定以分子形态存在、生物利用度高。此专利取得虽不对公司生产经营产生重 大影响，但利于技术创新、完善知识产权保护体系及增强核心竞争力。 ...